Double-blind and Placebo-controlled Study on Intervention Effect of Medium and Long Chain Fatty Acid Triglyceride on Glycolipid Homeostasis in Patients With Metabolic Syndrome and Mechanisms - Trial NCT06210230
Access comprehensive clinical trial information for NCT06210230 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhejiang University and is currently Completed. The study focuses on Metabolic Syndrome. Target enrollment is 240 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhejiang University
Timeline & Enrollment
N/A
May 22, 2023
Dec 10, 2023
Primary Outcome
Change in blood glucose from baseline,Change in blood lipids from baseline
Summary
Double-blind and placebo-controlled study on intervention effect of medium and long chain
 fatty acid triglyceride on glycolipid homeostasis in patients with metabolic syndrome and
 mechanisms
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06210230
Non-Device Trial